Thymus & immune

What actually decides this outcome, in order of size

This pathway is the best-supported corner of the bioregulator program and it is still an argument about evidence architecture rather than about mechanism. Ranked by how much of the outcome each factor owns:

1. WHAT IS ACTUALLY IN THE VIAL, which precedes every efficacy question and is rarely asked. The products here are not one thing. Thymalin is a peptide fraction whose dipeptide composition has been analyzed in the drug preparation itself Linkova 2023; Thymogen is a synthetic dipeptide; Timusamin and Vladonix are organ concentrates sold under a food-supplement category. A two-amino-acid peptide, a chromatographic fraction and a ground gland are three different pharmacological objects wearing one shelf label.
2. The regulatory category the product was sold under, because it decides what evidence was ever required. Some of these have been registered medicines in one jurisdiction and food supplements in another. The review literature written by the program's own authors describes the use case Khavinson 2021 Kuznik 2021, and reading it as regulatory-grade evidence rather than as a program summary is the commonest mistake made with this shelf.
3. The endpoint the original studies chose, which is the hardest one there is. The geroprotective work reported on thymalin and epithalamin together Khavinson 2002, and the follow-up claim is that pineal and thymic peptides prolong human life Khavinson 2003. Mortality is the least gameable endpoint in medicine and also the one most sensitive to how a cohort was assembled and followed. Both things are true and the second is why the result has not traveled.
4. Whether a short peptide survives to signal anything, which is the mechanistic hinge. These are given by injection in the original work and sold orally in the West. Oral dipeptides face brush-border peptidases and first-pass metabolism, and the claim that an intact signaling dipeptide reaches a tissue after an oral capsule is an extrapolation from the injectable literature rather than a demonstrated result. That gap is the single largest unstated assumption on this page.
5. What the supporting studies actually measured. A thymalin study reported on immune response in people given an influenza vaccination Degtiarev 1988; nucleolar organizer region proteins were used as the readout in another Raikhlin 2004; a more recent report examined lymphocyte and macrophage expression in post-traumatic regeneration Boiko 2024. These are mechanism and surrogate endpoints, and they are informative about engagement rather than about outcome.
6. The thymus-pineal relationship, which is the program's own framing. The axis has been revisited in the modern literature Rezzani 2020, and it is the reason these products are almost always sold alongside the pineal ones at Brain & pineal.

The order to run these in, and what has to be true first

The order below is by how much is known about the specific preparation, not by how the marketing ranks them. On this shelf the identity question comes before the dose question.

1. Decide whether the direction is right for you before the product. This is an adaptive-immunity shelf, so autoimmune history changes the calculation. The measurement side of that argument is at Thymic function & adaptive immunity, and it should be read first.
2. Baseline bloods, because they are the only objective thing available. Complete Blood Count (CBC) with Differential with differential, hs-CRP (High-Sensitivity C-Reactive Protein), ESR (Sed Rate), Vitamin D (25-Hydroxy) and Zinc, Plasma. None of these measures thymic output Middelkamp 2025; all of them catch the ordinary explanations for feeling run down.
3. Thymalin is the preparation with the most published material behind it and the clearest compositional analysis Linkova 2023 Khavinson 2021. If any item here is going to be tried, this is the one with the most to read first.
4. Thymogen is the synthetic dipeptide and is the most chemically defined item on the page. Defined is not the same as demonstrated, and the distinction is worth holding: you know what you are taking, not what it does.
5. Thymulin is a zinc-dependent thymic hormone by name, which means zinc status is part of the pharmacology rather than an afterthought. Correcting a measured zinc deficiency is cheaper and better evidenced than anything else on this page.
6. Timusamin, Vladonix, Crystagen and Bonomarlot are the organ-concentrate end. They are ground and processed tissue standardized to a peptide content, and the specific-signal claim made for them is a theory carried over from the injectable fractions Khavinson 2002. Bonomarlot is a bone marrow preparation rather than a thymic one, which is a different tissue with a different argument.
7. Thymosin Alpha 1 is on this list and does not belong to this program at all. It is a defined synthetic peptide with randomized clinical trials in patient populations, and its evidence is discussed at Thymic function & adaptive immunity. Grouping it with the organ concentrates flatters them and undersells it.

What gets bought for this that cannot move it

The category that fails structurally is the oral organ concentrate sold on injectable evidence. The founding studies for this program used parenteral preparations Khavinson 2002 Degtiarev 1988. The products most readers can buy are oral capsules of processed tissue. Between those two sits gastric acid, brush-border peptidase and hepatic first pass, and no published human pharmacokinetic study establishes that an intact signaling peptide crosses that gap in a quantity that matters. That is a prediction from peptide pharmacology rather than a measured failure, and it is labeled as one — but it is the assumption the entire oral market rests on and nobody selling into it states it.

The evidence problem is not that the studies are Russian. It is that the strongest claim rests on a small number of long-running cohorts reported by the same group Khavinson 2003 Khavinson 2002, with mechanism-level and surrogate endpoints elsewhere Raikhlin 2004 Boiko 2024. Mortality is the right endpoint to have chosen; a mortality claim that has not been reproduced by an independent group in two decades is a claim that is still waiting, and a reader is entitled to know that is the shape of it.

The specific mismatch is age. This is an involution argument Liang 2022: the target organ is one that shrinks from puberty and is largely fat by sixty. That makes the population in whom restoring a signal could plausibly matter an older one. A thirty-year-old buying a thymic peptide is buying it for an organ that has not yet done most of its involuting, which is the clearest case on this shelf of the right product and the wrong reader.

If the goal underneath is different, so is the page. If the question is what can be measured, Thymic function & adaptive immunity. If it is the pineal half of the same program, Brain & pineal. If it is the endocrine tissues, Endocrine & reproductive. And if the goal is fewer infections this winter, the innate-immunity page is a better-evidenced place to spend money than any of them.

How you would know it was working, on a real read-out and a real timescale

This page makes two predictions. Nothing here will move a marker that specifically reports thymic activity, because that assay is not available at consumer level Middelkamp 2025; and a Complete Blood Count (CBC) with Differential with differential plus Zinc, Plasma will explain more of how somebody feels than any of these preparations will change.

• Complete Blood Count (CBC) with Differential with differential at baseline and 12 weeks. The closest routinely available number to this page's subject, and a crude one; twelve weeks because lymphocyte populations move slowly outside acute illness.
• Zinc, Plasma at baseline and 12 weeks. Thymulin is zinc-dependent by definition, so this is the one measurement on the page that sits inside the stated mechanism rather than beside it.
• hs-CRP (High-Sensitivity C-Reactive Protein) with ESR (Sed Rate) at baseline and 12 weeks. Two inflammatory markers with different time constants; a rise on an immune-directed product is a reason to stop rather than a sign of engagement.
• Comprehensive Metabolic Panel (CMP) at baseline and 12 weeks. These are unlicensed preparations in most jurisdictions, frequently taken in cycles for years, and liver and renal chemistry is the cheapest safety net available.
• Vitamin D (25-Hydroxy) once at the start. Common, correctable, and the item on this shelf with actual randomized immune-endpoint data behind it.

What will fool you. These products are usually run in ten-to-twenty-day courses, which is short enough that almost any coincident recovery gets attributed to the course. The surrogate endpoints in the supporting literature — nucleolar organizer proteins, cell-population counts Raikhlin 2004 Boiko 2024 — are measures of engagement rather than of benefit. A vaccination-response result Degtiarev 1988 is a specific immunological endpoint and not a general one. Reviews authored within the program Khavinson 2021 Kuznik 2021 are a description of the program rather than an independent assessment of it. And an oral capsule of an injectable-derived preparation has an absorption question in front of every efficacy question.

Sources read for these sections

• Khavinson VKh, Morozov VG. Geroprotective effect of thymalin and epithalamin. Advances in Gerontology 2002 [Russian] · PMID 12577695
• Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinology Letters 2003;24(3-4):233–240 · PMID 14523363
• Kuznik B, Khavinson V, Shapovalov K, Linkova N, Lukyanov S, Smolyakov Yu, Tereshkov P, Shapovalov Yu, Konnov V, Tsybikov N. Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients. Advances in Gerontology 2021;11(4):368–376
• Khavinson VKh, Linkova NS, Chalisova NI, Ivko OM. The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity. Biology Bulletin Reviews 2021;11(4):377–382
• Linkova N. The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19. International Journal of Molecular Sciences 2023 · PMID 37686182
• Degtiarev AA. Use of thymalin in stimulating an immune response in subjects inoculated with influenza vaccine. Voenno-Meditsinskii Zhurnal 1988 [Russian] · PMID 3206835
• Raikhlin NT. Expression of argyrophilic proteins in the nucleolar organizer regions of human thymocytes and thymic epitheliocytes under conditions of coculturing with vilon and epithalon peptides. Bulletin of Experimental Biology and Medicine 2004 · PMID 15455093
• Boiko AA. Expression features of T-lymphocytes, B-lymphocytes and macrophages in the post-traumatic regenerate of the mandible rats under conditions of filling a bone defect with hydroxyapatite-containing osteotropic material and thymalin injecting the surrounding soft tissues. Polski Merkuriusz Lekarski 2024 · PMID 38642352
• Rezzani R, et al. Thymus-Pineal Gland Axis: Revisiting Its Role in Human Life and Ageing. International Journal of Molecular Sciences 2020 · PMID 33233845
• Middelkamp V. Measuring thymic output across the human lifespan: a critical challenge in laboratory medicine. GeroScience 2025 · PMID 39946072
• Liang Z. Age-related thymic involution: Mechanisms and functional impact. Aging Cell 2022 · PMID 35822239